Scribd Logo
Upload

Welcome to Scribd!

  • 2 MasterCapTable 2021 06 28

    Uploaded by

    MD.SHAHNEWAZ Mazumder
    6 views1 page
    This document summarizes NowRX's capitalization table as of June 28, 2021. It shows that NowRX has authorized 30 million common shares, of which 8.6 million have been issued. It also has authorized 16.5 million preferred shares, of which 8.8 million Series A shares and 6.5 million Series B shares have been issued. The company also has outstanding stock options allowing the purchase of 1.1 million shares and warrants for 10,000 shares. In total, including shares reserved under stock plans, the company has 25.3 million shares issued and outstanding.

    Original Description:

    Original Title

    2_MasterCapTable_2021_06_28

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This document summarizes NowRX's capitalization table as of June 28, 2021. It shows that NowRX has authorized 30 million common shares, of which 8.6 million have been issued. It also has authorized 16.5 million preferred shares, of which 8.8 million Series A shares and 6.5 million Series B shares have been issued. The company also has outstanding stock options allowing the purchase of 1.1 million shares and warrants for 10,000 shares. In total, including shares reserved under stock plans, the company has 25.3 million shares issued and outstanding.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    6 views1 page

    2 MasterCapTable 2021 06 28

    Uploaded by

    MD.SHAHNEWAZ Mazumder
    This document summarizes NowRX's capitalization table as of June 28, 2021. It shows that NowRX has authorized 30 million common shares, of which 8.6 million have been issued. It also has authorized 16.5 million preferred shares, of which 8.8 million Series A shares and 6.5 million Series B shares have been issued. The company also has outstanding stock options allowing the purchase of 1.1 million shares and warrants for 10,000 shares. In total, including shares reserved under stock plans, the company has 25.3 million shares issued and outstanding.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    Cap Table - Ownership Summary

    NowRX - Cap Table - Ownership Summary Report (report run on 28-Jun-2021 for reporting period 28-Jun-2021)
    Common
    Issued and
    Shares Stock Percent
    Outstanding
    Authorized Equivalent Ownership
    Shares
    Shares
    COMMON STOCK 30,000,000
    Common 30,000,000 8,595,000 8,595,000 33.9069%
    8,595,000 8,595,000

    PREFERRED STOCK 16,500,000


    Series A 10,000,000 8,841,611 8,841,611 34.8798%
    Series B 6,500,000 6,497,179 6,497,179 25.6311%
    15,338,790 15,338,790

    WARRANTS
    Warrants (Common)
    Outstanding 10,000 10,000 0.0394%
    10,000 10,000

    Reserved: 1,500,000, Share Pool: 2015 Stock Incentive Plan


    2015 Stock Incentive Plan
    Granted 1,862,151
    Exercised -95,000
    Repurchased 0
    Cancelled -618,562
    Awards Outstanding 1,148,589 1,148,589 4.5311%

    Shares Remaining For Issuance 256,411 256,411 1.0115%


    Awards Outstanding + Shares Remaining for Issuance 1,405,000 5.5427%
    1,405,000 1,405,000

    Reserved: 0, Share Pool: Stock With Vesting Non-Plan Share Pool


    Plan Name: N/A
    Granted 0
    Exercised 0
    Repurchased 0
    Cancelled 0
    Awards Outstanding 0 0 0.00%

    Shares Remaining For Issuance 0 0 0.00%


    Awards Outstanding + Shares Remaining for Issuance 0 0.00%
    0 0

    25,348,790 25,348,790

    Total shares issued and outstanding, including shares committed for issuance and reserves, assuming conversion of all
    convertible securities and exercise of all outstanding awards.
    CSE Shares* - Common Stock Equivalent (CSE) shares reflects the Common Stock issuable for the security type (option, stock,
    warrant, notes/debt) after the appropriate conversion ratio is applied with regard to parameters set for aggregation/rounding for
    each class/series.

    1/1 8/14/21

    You might also like